The regulator also wanted to know why shareholders would subscribe for these shares when they could purchase them from the market at a lower price.
SINGAPORE (Oct 4): Shares of Trendlines Group, the investor of medical and agricultural technology startups, saw heavy trading on Friday after the group said its current market price "does not properly reflect the company's value".
This was in response to a query by the Singapore Exchange (SGX) asking why the firm had priced the rights shares at 10.5 cents, which is at a 19.3% premium to the counter's last trading price of 8.8 cents on Sept 26.
